Colin Larkworthy

 

           
Person icon

Clinical Trial Support Officer

Jenner Institute, University of Oxford

Email: Colin.larkworthy@ndm.ox.ac.uk; colin.larkworthy@gmail.com  

                                                              

 

 

 

VALIDATE Role:

Network Affiliate

 

Research area keywords:

TB, Clinical Trials of Everything

 

Key publications:

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses, Folegatti, P et al (2020) – part of the Oxford Vaccine Centre Team.

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trials - Maheshi N Ramasamy et al (2020) – Part of the Oxford Vaccine Centre Team